Take a look at which therapy areas and companies pushed the industry forward last year.
FDA approvals of innovative medical devices fell off a cliff last year. Only 23 products made it to market via a first-time PMA or humanitarian device exemption in 2013. That’s more than the 18 seen back in 2010 but still a 44% drop over 2012, according to EP Vantage. Here’s a breakdown of where innovations in the industry came from in 2013:
(click to enlarge)